Global Clinical Trials Landscape Market research gain impetus due to the growing demand over 2019 - 2029

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases.
The ubiquity digital technologies is evidently growing, as these (including but not limited to ingestible devices, sensors, and wearable health monitors) hold the potential to disrupt the aspects of clinical trials. Digital technologies are revolutionizing the antiquated process of new drug development, even as optimizing the way health data is collected, measured, and assessed”.
According to the study, the clinical trials landscape is witnessing a paradigm shift toward patient centricity, in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels during the study’s execution. Key enterprises are adopting unconventional approaches by implementing site-centric method, using operational support systems and technology for bringing studies to the trial-naïve physicians.
Industry Sponsors Account for Majority Clinical Trial Spending
The most remarkable advances in medicine are realized from sponsorships of companies for clinical trials, in the anticipation of turning a profit. A notable percentage of clinical trials being conducted to support approval of vaccines, devices, or drugs, and track their safety, have been industry-sponsored in recent years.
The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. Recent studies state that industry-sponsored trials yield positive results compared to academic-run trials, which also account for a significant share of clinical trial spending.
According to FMI, sponsors, such as academic institutes, research institutes and medical centers, are estimated to account for ~30% clinical trial spending in 2019. As the imperativeness of evidence-based therapies continue to be progressively emphasized, most of the randomized clinical trials are driven by the ability of developing profitable new therapies. Guidelines recommended by regulatory bodies for clinical trial enrichment, and risk-based monitoring are likely to lay the groundwork for more targeted approach toward cost-intensive clinical trials.
The study opines that North America and Europe will continue to lead the clinical trials landscape, collectively accounting for ~80% of global spending. These regions present a standardized and favorable environment for the clinical trials landscape, in light of their economic vigor that enables them to benefit from most of the technology disruptions prior to other nations. Pharmaceutical and medical device giants in these two regions are adopting AI for disrupting every stage of the clinical trial, which range from linking studies to eligible patients, to data collection and adherence.
According to the study, opportunities abound for conducting clinical trials in developing economies, such as in East Asia and South Asia, owing to the access to huge patient pool. Sponsors are likely to realize greater success in these regions as low government healthcare budgets represent cost-effective methods of providing patients with access to innovative therapies. Additionally, conducting clinical trials in these regions comes with other broader advantages, including pragmatic & efficient regulatory pathway, and tax incentives for conducting the trials.

Comments

Post a Comment

Popular posts from this blog

Global Dairy Machines Market research to Witness an Outstanding Growth During 2018 – 2028

VALLEY COTTAGE, N.Y. –  Dairy Machines Market: Definition and Introduction Dairy Machines encompass all machinery used in the extraction, processing, packaging, storage, preservation, transport and sale of dairy products. Dairy Machines are used across the dairy industry value chain, from production to retail. Dairy Machines are used in various different processes and are used to help improve the quality of dairy products as well as reduce the overall cost of operations. Dairy Machines used in the production and processing of milk and milk products include equipment, such as milking machines (milk extraction machines), separators, pasteurizers, dryers and evaporators, separators, filtration machines, homogenizers, etc. Dairy Machines used in the storage and transportation of dairy products include refrigeration machines, such as freezers, coolers, chillers, etc. These refrigeration Dairy Machines can be fixed or mobile or even truck mountable. Dairy Machines, such as automatic mild
Read more

Laboratory Filtration Equipment and Supplies Market to Approach US$ 2.1 Bn by 2019 - 2027

VALLEY COTTAGE -The ultrafiltration technique is becoming a preferred choice among end users in the laboratory filtration equipment and supplies market. Recent improvements in cartridge configurations and varied membrane types have enhanced the technical reliability for large volume applications such as industrial waste water treatment and surface water treatment. A new report by Future Market Insights (FMI) presents a comprehensive revenue assessment of the global laboratory filtration equipment and supplies market and throws light on the various factors influencing growth in sales of laboratory filtration equipment and supplies. The study further highlights various developments among the leading players operating in the laboratory filtration equipment and supplies market. Key Developments in the Laboratory Filtration Equipment and Supplies Market In 2018, Merck, a Germany-based manufacturer of laboratory filtration equipment and supplies, launched a user-friendly single-use flo
Read more

Research details developments in the Global Automotive Control Cable Market research future scenario by 2019-2029

A new market research study by Future Market Insights on the automotive control cable market contains global industry analysis 2014–2018 and opportunity assessment 2019–2029. The report investigates the  automotive control cable market  and provides critical insights for the forecast period of 2019-2029. As per the findings of the report, the ~US$ 2.1 Bn market for automotive control cable will witness a moderate 4% annual rise in the revenues, by 2019 end. New vehicle model launches, and the spectacular rise in vehicle parc, have been the leading market growth influencers. While gains are majorly driven by the increasing demand for automotive vehicles, government mandates regarding anti-lock braking systems for passenger and commercial vehicles, are identified to remain the key growth determinants for market. This scenario will particularly prevail in developing countries, such as India, China, and Brazil, among others, according to FMI’s analysis. Download Sample Copy@  https:/
Read more